​

Instil Bio (TIL) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

TIL Stock Forecast

Instil Bio (TIL) stock forecast, based on 7 Wall Street analysts, predicts a 12-month average price target of $7.00, with a high of $7.00 and a low of $7.00. This represents a -0.99% decline from the last price of $7.07.

$5 $18 $31 $44 $57 $70 High: $7 Avg: $7 Low: $7 Last Closed Price: $7.07

TIL Stock Rating

Instil Bio stock's rating consensus is Hold, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 3 Buy (42.86%), 4 Hold (57.14%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Hold
Total 7 0 4 3 Strong Sell Sell Hold Buy Strong Buy

TIL Price Target Upside V Benchmarks

TypeNameUpside
StockInstil Bio-0.99%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts111
Avg Price Target$7.00$7.00$7.00
Last Closing Price$7.07$7.07$7.07
Upside/Downside-0.99%-0.99%-0.99%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 26-31--4
Dec, 25-31--4
Nov, 25121--4
Oct, 25121--4
Sep, 25121--4
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 06, 2026Robert W. Baird$7.00$6.527.36%-0.99%
Sep 16, 2024Jack AllenRobert W. Baird$180.00$65.58174.47%2445.97%
Sep 16, 2024Mitchell KapoorH.C. Wainwright$120.00$84.5241.98%1597.31%
Sep 12, 2024Mitchell KapoorH.C. Wainwright$40.00$39.192.07%465.77%
Apr 12, 2024Kelly ShiJefferies$11.00$11.06-0.54%55.59%
Dec 12, 2022Morgan Stanley$2.00$0.84138.10%-71.71%
Jun 05, 2022Vikram PurohitMorgan Stanley$9.00$6.0149.75%27.30%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jan 07, 2026H.C. WainwrightBuyNeutraldowngrade
May 23, 2025H.C. WainwrightBuyBuyhold
Nov 04, 2024JMP SecuritiesMarket Performinitialise
Sep 16, 2024H.C. WainwrightBuyBuyhold
Aug 23, 2024H.C. WainwrightBuyBuyhold
Apr 12, 2024JefferiesHolddowngrade
Dec 12, 2022Morgan StanleyEqual-WeightEqual-Weighthold

Financial Forecast

EPS Forecast

$-35 $-29 $-23 $-17 $-11 $-5 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-24.30$-34.46$-24.00$-11.39----
Avg Forecast$-25.05$-33.13$-24.85$-12.72$-13.22$-7.99$-10.85$-11.06
High Forecast$-25.05$-33.13$-24.85$-12.63$-8.46$-7.99$-10.85$-11.06
Low Forecast$-25.05$-33.13$-24.85$-12.81$-17.97$-7.99$-10.85$-11.06
Surprise %-2.99%4.01%-3.42%-10.46%----

Revenue Forecast

$4M $5M $6M $7M $8M $9M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported--------
Avg Forecast$46.00K$500.00K-$3.75M$3.85M$3.98M$8.20M$8.44M
High Forecast$46.00K$500.00K-$3.75M$3.85M$3.98M$8.20M$8.44M
Low Forecast$46.00K$500.00K-$3.75M$3.85M$3.98M$8.20M$8.44M
Surprise %--------

Net Income Forecast

$-250M $-210M $-170M $-130M $-90M $-50M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-156.79M$-223.18M$-156.09M$-74.14M----
Avg Forecast$-162.92M$-215.50M$-161.62M$-82.71M$-76.73M$-51.93M$-70.57M$-71.93M
High Forecast$-162.92M$-215.50M$-161.62M$-82.12M$-55.03M$-51.93M$-70.57M$-71.93M
Low Forecast$-162.92M$-215.50M$-161.62M$-83.31M$-116.89M$-51.93M$-70.57M$-71.93M
Surprise %-3.76%3.56%-3.42%-10.37%----

TIL Forecast FAQ

Is Instil Bio stock a buy?

Instil Bio stock has a consensus rating of Hold, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 3 Buy, 4 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Instil Bio is a neutral investment for most analysts.

What is Instil Bio's price target?

Instil Bio's price target, set by 7 Wall Street analysts, averages $7 over the next 12 months. The price target range spans from $7 at the low end to $7 at the high end, suggesting a potential -0.99% change from the previous closing price of $7.07.

How does Instil Bio stock forecast compare to its benchmarks?

Instil Bio's stock forecast shows a -0.99% downside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Instil Bio over the past three months?

  • January 2026: 0% Strong Buy, 75.00% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.
  • December 2025: 0% Strong Buy, 75.00% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.
  • November 2025: 25.00% Strong Buy, 50.00% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.

What is Instil Bio’s EPS forecast?

Instil Bio's average annual EPS forecast for its fiscal year ending in December 2025 is $-13.22, marking a 16.07% increase from the reported $-11.39 in 2024. Estimates for the following years are $-7.99 in 2026, $-10.85 in 2027, and $-11.06 in 2028.

What is Instil Bio’s revenue forecast?

Instil Bio's average annual revenue forecast for its fiscal year ending in December 2025 is $3.85M, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $3.98M, followed by $8.2M for 2027, and $8.44M for 2028.

What is Instil Bio’s net income forecast?

Instil Bio's net income forecast for the fiscal year ending in December 2025 stands at $-76.731M, representing an 3.50% increase from the reported $-74.135M in 2024. Projections indicate $-51.934M in 2026, $-70.567M in 2027, and $-71.933M in 2028.